Previous close | 53.01 |
Open | N/A |
Bid | 46.25 |
Ask | 48.40 |
Strike | 115.00 |
Expiry date | 2024-08-16 |
Day's range | 53.01 - 53.01 |
Contract range | N/A |
Volume | |
Open interest | 42 |
AbbVie (NYSE: ABBV) announced today that it has completed its acquisition of Landos Biopharma, Inc. (NASDAQ: LABP). With the completion of the acquisition, Landos is now part of AbbVie.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Eli Lilly's (LLY) stock hits an all-time high after announcing detailed results from a late-stage study on mirikizumab in Crohn's disease.